Customize your JAMA Network experience by selecting one or more topics from the list below.
Author Affiliations: Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois (Dr McDermott). Dr McDermott is Contributing Editor and Dr Livingston is Deputy Editor, JAMA.
In this issue, a new article type is launched: JAMA Clinical Evidence Synopsis.1 JAMA Clinical Evidence Synopsis will appear approximately once per month in JAMA and will concisely summarize a high-quality systematic review, typically from the Cochrane Collaboration or the US Preventive Services Task Force. This new article type will cover clinical topics of interest to the practicing clinician. JAMA Clinical Evidence Synopsis will distill the most important information from longer systematic reviews, enabling clinicians to easily understand the evidence and key take-home messages that are relevant to daily medical practice.
To ensure that JAMA Clinical Evidence Synopsis articles are timely and topical, typically only systematic reviews published during the previous 18 to 24 months will be selected for summary. For instance, in this issue of JAMA, Carson and colleagues1 address the important issue of whether a lower or higher hemoglobin threshold is a better trigger for red blood cell transfusion with regard to minimizing such transfusions and adverse clinical outcomes among patients with anemia in critical care settings. The synopsis is based on the authors' Cochrane Collaboration review, published in April 2012. Occasionally, older systematic reviews may be selected if the topic is particularly relevant to a current health issue, such as epidemics of infectious disease.
McDermott MM, Livingston EH. Introducing JAMA Clinical Evidence Synopsis: From Systematic Reviews to Clinical Practice. JAMA. 2013;309(1):89. doi:10.1001/jama.2012.148063
Create a personal account or sign in to: